-- 根據週一提交給澳洲證券交易所的文件顯示，Cyclopharm（ASX：CYC）已任命Doug Cubbin為非執行董事長，該任命將於上週五公司年度股東大會結束後，David Heaney退休時生效。 文件也補充道，Cubbin目前在GAIASO Theranostics擔任董事及高階主管。 該公司股價在周一的交易中上漲了1%。
Related Articles
Asia
Yuexiu Property to Dispose Assets, Businesses in 4.5 Billion Yuan Deal
Yuexiu Property (HKG:0123) agreed to dispose of a portfolio of assets and businesses through the transfer of target companies to connected parties, according to a Monday Hong Kong bourse filing.The transactions involve assets including Nansha IFC, Yungu Industrial Park, Zhigu Industrial Park, Bijie Hotel, and healthcare, nursing, and elderly care businesses, the filing showed.Total net proceeds are estimated at 4.46 billion yuan, with about 400 million yuan to be used for debt repayment and the remaining 4.06 billion yuan for working capital.Following completion, the target companies will cease to be subsidiaries and their financial results will no longer be consolidated.
$HKG:0123
Asia
Kotak Mahindra Bank's Consolidated Profit Rises in Fiscal Q4
Kotak Mahindra Bank's (NSE:KOTAKBANK, BOM:500247) consolidated profit after tax rose to 54.2 billion Indian rupees in the fiscal fourth quarter ended March 31, from 49.3 billion rupees a year ago.Earnings per share came in at 5.45 rupees from 4.96 rupees a year earlier, according to a Saturday filing to the Indian stock exchanges.Interest earned by the lender in fiscal Q4 increased to 178.3 billion rupees from 167.7 billion rupees a year ago.The bank's board proposed a dividend of 0.65 rupees per share, having a face value of 1 rupee each, for the year ended March 31.
$BOM:500247$NSE:KOTAKBANK
Asia
Victory Metals Finalizes Test Work Inputs for Western Australia Project Pre-Feasibility Study; Shares Down 3%
Victory Metals (ASX:VTM) finalized key metallurgical test work inputs for its pre-feasibility study on the North Stanmore project in Western Australia, delivering capital and operating expenditure reduction opportunities, according to a Monday filing with the Australian bourse.The study is on track for delivery in the second quarter, the filing said.Shares fell 3% in midday trade on Monday.
$ASX:VTM